Green Cross Company Profile

04:33 EDT 2nd September 2015 | BioPortfolio

Green Cross is an exemplary R&D-oriented company that leads the biotechnology industry in Korea. This is clear given what Green Cross has achieved since its foundation in 1967. Starting from the nation's first production and sales of Plasma Fractions in 1970, which required sophisticated technology, Green Cross has striven to develop ethical drugs that are hard to produce but essential to patients. Subsequently, it is now an internationally recognized biotechnology company in the fields of virus and bacteria.

Location

303 Bojeong-Dong, Giheung-Gu
Yongin-Si
Gyeonggi-Do
449-770
South Korea

Contact

Phone: 82-31-260-9300
Fax: 82-31-260-9413


News Articles [668 Associated News Articles listed on BioPortfolio]

Green Cross spends $255M on immunoglobulin, albumin manufacturing site

Green Cross subsidiary Green Cross Biotherapeutics is investing $255 million in the construction of its new immunoglobulin an -More- 

INTERVIEW: Green Cross Looks Abroad To Expand

Green Cross Holdings, which has South Korea's leading biopharma company Green Cross Corp. as its affiliate, talks to PharmAsia News about its strategies on acquisitions, international business plans a...

Green Cross Juventas Investment Shows Gene Therapy Appetite

South Korea's Green Cross Holdings has invested in the clinical-stage U.S. biotech firm Juventas Therapeutics in a bid to diversify into the cell and gene therapy sector. Along with Posco Capital, Gre...

Green Cross Corporation - Product Pipeline Review - 2015

Green Cross Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Green Cross Corporation - Product Pipeline Review - 2015’, provides an overview of the Green Cross Corp...

Green Cross Biotherapeutics Builds Canadian Manufacturing Facility

The Green Cross facility in Canada will produce intravenous immunoglobulin and albumin. Date:  Mon, 2015-06-08 (All day) read more

Green Cross Biotherapeutics Constructs Manufacturing Facility in Canada

The Canadian Green Cross facility will produce intravenous immunoglobulin and albumin. Date:  Mon, 2015-06-08 (All day) read more

Green Cross receives approval for hepatitis B treatment study

Green Cross was granted approval from the South Korean Ministry of Food and Drug Safety to initiate an early-stage trial of i -More- 

Nanotek Biologics Deal Gives Green Cross Route To Russia

Following its entry into North America and China, Green Cross is set to make inroads into the rapidly growing Russian pharmaceutical market through a strategic partnership with Nanolek to commercializ...

PubMed Articles [1351 Associated PubMed Articles listed on BioPortfolio]

Associations between Green Space and Health in English Cities: An Ecological, Cross-Sectional Study.

Green space has been identified as a modifiable feature of the urban environment and associations with physiological and psychological health have been reported at the local level. This study aims to ...

Capture cross section measurement analysis in the Californium-252 spectrum with the Monte Carlo method.

Absolute average capture cross sections of gold, thorium, tantalum, molybdenum, copper and strontium in (252)Cf spontaneous fission neutron spectrum were simulated for two types of experiment setups p...

Correction: Associations between Green Space and Health in English Cities: An Ecological, Cross-Sectional Study.

[This corrects the article DOI: 10.1371/journal.pone.0119495.].

Pd(OAc)2 in WERSA: a novel green catalytic system for Suzuki-Miyaura cross-coupling reactions at room temperature.

A recyclable/reusable Pd(OAc)2 catalysed Suzuki-Miyaura cross-coupling reaction condition in neat "Water Extract of Rice Straw Ash" (WERSA) at room temperature was developed. This is a ligand/base/pro...

Building green supply chains in eco-industrial parks towards a green economy: Barriers and strategies.

As suggested by UNEP, the key to sustainable development is to create a "green economy" which should encapsulate all three sectors: the industry, the people, and the government. Therefore, there is an...

Clinical Trials [771 Associated Clinical Trials listed on BioPortfolio]

Green Tea Anticancer Mechanisms in Smokers

The purpose of this study is to determine whether green tea may lower the risk of certain cancers.

Cardioprotective Effects of Green Tea Versus Maté Intake

The investigators aim to study the effects of green tea and maté consumption on lipid and inflammatory profiles in dyslipidemic and overweight subjects.

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

RATIONALE: Green tea extract (Polyphenon E) contains ingredients that may prevent the development of cancer. PURPOSE: This phase I trial is studying how well green tea extract works in pr...

Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson’s Disease Patients

The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson’s disease Patients with...

Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine

The purpose of this study is to determine if taking green tea capsules can help prevent weight gain in patients that start therapy with Zyprexa® (olanzapine).

Companies [515 Associated Companies listed on BioPortfolio]

Green Cross

Green Cross is an exemplary R&D-oriented company that leads the biotechnology industry in Korea. This is clear given what Green Cross has achieved since its foundation in 1967. Starting from the natio...

Anthem Blue Cross in California

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. ® ...

Blue Cross and Blue Shield of Georgia

Blue Cross and Blue Shield of Georgia, Inc. and Blue Cross and Blue Shield Healthcare Plan of Georgia, Inc. are independent licensees of the Blue Cross and Blue Shield Association® . The Blue Cross a...

Blue Cross and Blue Shield of Georgia, Inc.

Blue Cross and Blue Shield of Georgia, Inc. and Blue Cross and Blue Shield Healthcare Plan of Georgia, Inc. are independent licensees of the Blue Cross and Blue Shield Association(® ). The Blue Cross...

Blue Cross Blue Shield of Georgia

Blue Cross and Blue Shield of Georgia, Inc. and Blue Cross and Blue Shield Healthcare Plan of Georgia, Inc. are independent licensees of the Blue Cross and Blue Shield Association® . The Blue Cross a...

More Information about "Green Cross" on BioPortfolio

We have published hundreds of Green Cross news stories on BioPortfolio along with dozens of Green Cross Clinical Trials and PubMed Articles about Green Cross for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Green Cross Companies in our database. You can also find out about relevant Green Cross Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2014 Top 10 biotech and pharmaceutical companies worldwide based on market value in 2014 (in billion U.S. dollars) data Johnson & Johnson, U.S. 2...

Blood
Latest News Clinical Trials Research Drugs Reports Corporate
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record